The Competition Commission of India (CCI) has approved the acquisition of 100% equity shares of Medlife International Private Limited (“Medlife”) by API Holdings Private Limited (“API Holdings”). It also approved the acquisition of up to 19.59% equity share capital of API Holdings by Medlife’s shareholders under Section 31(1) of the Competition Act, 2002.
API is a private company, incorporated in 2019. API directly or through its subsidiaries carries out various business activities including wholesale sale and distribution of drugs; transportation and delivery services primarily focused on pharmaceutical sector; owning technology and intellectual property for developing e- commerce platforms. Medlife is primarily a healthcare company engaged in the wholesale sale and distribution of drugs.
Important takeaways for all competitive exams:
National News Padma Awards 2026 Honor India’s Distinguished Achievers President Droupadi Murmu conferred 65 Padma…
United Nations Secretary-General António Guterres has issued the strong warning about the growing dangers of…
The State government of Rajasthan has constituted a five-member committee to prepare a draft law…
India's first Made In India C295 transport aircraft is set to be delivered to the…
On 23rd to 24th June, 2026 in Bengaluru India hosting the BRICS Heads of Space…
India has secured the 13th position in the QS World Future Skills Index of 2027…